Clinical Research Directory
Browse clinical research sites, groups, and studies.
Sclerotherapy and Candida Antigen in Treatment of Common Warts
Sponsor: Sohag University
Summary
This study aims to evaluate the efficacy and safety of intralesional injections of candida antigen, polidocanol sclerotherapy and combined candida antigen with polidocanol in treatment of patients with common warts.
Official title: Efficacy and Safety of Intralesional Injections of Candida Antigen, Polidocanol Sclerotherapy and Combined Candida Antigen With Polidocanol in Treatment of Patients With Common Warts
Key Details
Gender
All
Age Range
18 Years - 60 Years
Study Type
INTERVENTIONAL
Enrollment
75
Start Date
2024-12-20
Completion Date
2025-12-01
Last Updated
2024-12-27
Healthy Volunteers
Yes
Conditions
Interventions
polidacanol 3%
Aethoxysklerol 3%,60mg/ ml ampoule, kreussler pharma, Germany
candida antigen
delayed type of hypersensitivity reaction is induced toward the injected antigen and the wart virus as well. This can increase the ability of the immune system to recognize and eradicate the human papillomavirus on various parts of the body and eliminate the necessity of local treatment for each wart
Locations (1)
Sohag university hospital
Sohag, Egypt